/Companies

Digi Bio

1 known investors

Find your way into Digi Bio

Sign up to see every warm intro you have to Digi Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Digi Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Digi.Bio develops a single-cell, AI-driven, lab-on-a-chip platform that profiles the fate and performance of individual cells to evaluate how therapies perform over time. The technology, aimed at drug developers working on cell-based and immune therapies, measures cytotoxicity, cell motility, and cell-cell interactions to compare drug efficacy.

Founders & leadership

FM
Federico MuffattoFounder & CEO

Investors · 1

Frequently asked questions

What does Digi Bio do?
Digi.Bio develops a single-cell, AI-driven, lab-on-a-chip platform that profiles the fate and performance of individual cells to evaluate how therapies perform over time. The technology, aimed at drug developers working on cell-based and immune therapies, measures cytotoxicity, cell motility, and cell-cell interactions to compare drug efficacy.
Who are Digi Bio's investors?
Digi Bio's investors include SOSV.